{"name":"Chronos Therapeutics Ltd","slug":"chronos-therapeutics-ltd","ticker":"","exchange":"","domain":"","description":"","hq":"","founded":0,"employees":"","ceo":"","sector":"","stockPrice":0,"stockChange":0,"stockChangePercent":0,"marketCap":"","metrics":{"revenue":0,"revenueGrowth":0,"grossMargin":0,"rdSpend":0,"netIncome":0,"cash":0,"dividendYield":0,"peRatio":0,"fiscalYear":"FY2026"},"revenueBreakdown":[],"timeline":[{"date":"2026-07-28","label":"Q2 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2026-10-28","label":"Q3 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-01-28","label":"Q4 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-04-28","label":"Q1 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-07-28","label":"Q2 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-10-28","label":"Q3 2027 Earnings","type":"earnings","sentiment":"neutral"}],"diseaseAreas":[{"name":"Other","slug":"other","revenue":0,"percentOfTotal":0,"drugCount":1,"colorKey":"oncology","drugs":[{"name":"RDC5","genericName":"RDC5","slug":"rdc5","indication":"Other","status":"phase_1"}]}],"pipeline":[{"name":"RDC5","genericName":"RDC5","slug":"rdc5","phase":"phase_1","mechanism":"Small molecule","indications":[],"catalyst":""}],"recentEvents":[],"realNews":[{"url":"https://news.google.com/rss/articles/CBMijwJBVV95cUxQY2IwQlVIbmN2YjdvYlNtTHZ4SXE2SUZxbFRZc2t4eUlYV01Qck9Xc3FPVWhYbnBZczRsX0RaZzR3ZE1ENi1oeDFfbmVzWWExS0ctV0RvLUN1UE40S0FfMmx1T00ycVhmZWMzalRnSE50RXU1eWplQV9FV3hGSzg0NkY2R0NnQlJvbE5fV0VxUWdYSWZXelVybXo4S0xzSjZvT2g2Ni1FWTB3OGVBNm1SNEdRWGlMRnE5STh4NHhuM2hBeUllTF9tWkhjeWxjeFJDVXJzLTFmc0lMeG9Vd0pwU2hMOVJjQ29WV0VnMGxOYnNwQ1k3UFpHS2FJTzYzSDg0NEpHOFYyNjh2ZnFFZWY0?oc=5","date":"2026-04-01","type":"trial","source":"BioSpace","summary":"MaaT Pharma Announces Publication of Retrospective Data in Third-Line Acute GvHD from the CHRONOS Study in Bone Marrow Transplantation Journal - BioSpace","headline":"MaaT Pharma Announces Publication of Retrospective Data in Third-Line Acute GvHD from the CHRONOS Study in Bone Marrow T","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiqwFBVV95cUxPNXpVMVYxVkNvTTBhYll0MGhyNkVzTVdaaEc2N2ItWms1Z1dUQVBTZzZmbHNyZjc3STVmN2Z0SEJnRHFqWWhTWjA4cVVIWmdxejRUQlhnTmZPSUhfbDUzV1ZsbmpHTDhHRXdJaWtNbWFGdnlnV2YzNFZnY2lkMlRUSWtOR0FrWEpVbndtOHJ5eHM4RkZNa204cWNNdW5YLXcyNXBZOUhxbmh4YlE?oc=5","date":"2026-04-01","type":"pipeline","source":"CancerNetwork","summary":"Third-Line Therapy Shows Limited Efficacy in Real-World aGVHD Population - CancerNetwork","headline":"Third-Line Therapy Shows Limited Efficacy in Real-World aGVHD Population","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiowFBVV95cUxNVzlvdVUwVzFuUjRnUWl3Rk5YOTlPc1F0ODFzSUszdXZ1VWhZVjExNzFENnFBcXg3TjN5azdOWU1hSDNFWTNHeGVCN2tuT3B4Yk9zdU5aQnYxVzFQV3UwZGlVbHJVMEhXQXctWHFIWnRhczNZRXdyb1NDZXVhSmFHenJ5SkwyTlI2d3lxVzBOS3J4eDNQXzlScXhGcHc3SE9vWVFJ?oc=5","date":"2025-10-05","type":"pipeline","source":"The Observer","summary":"British firms hungry to join booming anti-obesity market - The Observer","headline":"British firms hungry to join booming anti-obesity market","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiakFVX3lxTFBBWHRYVFJhYmVBdklERDFVdTIxWlRkanhwNk1Sa3A4Ymp0dVg4OTkzbUlRZmhDSHhnZVpCQ0toQUY2N05SQXpnYzNKcktVajJtR2NYcGloN0IxYW1hQTRmYXZsUEZkTlpyRGc?oc=5","date":"2019-08-13","type":"trial","source":"Wiley Online Library","summary":"Laboratory safety of dupilumab in moderate-to-severe atopic dermatitis: results from three phase III trials (LIBERTY AD SOLO 1, LIBERTY AD SOLO 2, LIBERTY AD CHRONOS) - Wiley Online Library","headline":"Laboratory safety of dupilumab in moderate-to-severe atopic dermatitis: results from three phase III trials (LIBERTY AD ","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMipAFBVV95cUxOODhEeEl5QmItQm1DLUlMMG5kaUlCQXJVRm41eWJJTzducTVQZTVBdTd1VDNfa2RadDhrcnVHNWpQbTBMUlFCVDJpbXJVdVY0QUJrVUNkV0FIcEpuVEs2NXRpZ2NXaGNEeGNBdkpWSnNHdEtRTEhCcEVGZ2xiV0xaMzRRa3d1YXUxUTYyd1NMcVRqNXE2eUhyQllrdTNSSmZpb2poNA?oc=5","date":"2017-07-21","type":"pipeline","source":"European CEO","summary":"Mega Pharma targets global pharmaceutical markets - European CEO","headline":"Mega Pharma targets global pharmaceutical markets","sentiment":"neutral"}],"patents":[],"drugCount":1,"phaseCounts":{"phase_1":1},"enrichmentLevel":2,"visitCount":2,"keyCompetitors":[],"therapeuticFocus":[],"financials":null,"yahoo":null}